The Austrian Society for Dermatology and Venereology presents the yearly Science Award to scientists whose recent publications answer far-reaching…
The Paul G. Allen Frontiers Group has announced its 2022 selection of Allen Distinguished Investigators. Among the selected researchers is IMP Senior…
invIOs announced that CEO Peter Llewellyn-Davies will present a corporate update during the upcoming Biotech Showcase 2023 meeting in January.
The Austrian Science Fund FWF has allocated €2 million in funding to a joint doc.funds initiative coordinated by Javier Martinez. The course will…
Valneva reported positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate, VLA1553.
Valneva and Pfizer today reported antibody persistence data six months after the completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6)…
Group leader Sebastian Falk has been named a ‘Young Investigator’ for the next four years by the European Molecular Biology Organization (EMBO). The…
Researchers from the Tachibana lab show that the pioneer factor Nr5a2 can awaken the inactive genome in the early embryo. Part of this work was…
Two ERC Starting Grants were granted to two female group leaders at the Vienna BioCenter. IMBA researcher Joanna Jachowicz will investigate how the…
Organs grow into a variety of shapes and architectures. Observing what happens inside organs as they develop is difficult in living embryos, but…
Melanie de Almeida, a recent PhD graduate from the lab of Johannes Zuber, is among the first awardees of the Koch Institute’s Angelika Amon Young…
invIOs GmbH presented data from the ongoing clinical trial of its APN401 cell therapy at the 37th Annual Meeting of the Society for Immunotherapy of…
The website uses cookies to ensure you get the best experience on our website.
Anonymous evaluation for troubleshooting and further development
Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics Storage period: data on your device for up to two years. Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.